Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Exploratory, Randomized, Double-Arm, 8-week Study to Evaluate the Feasibility and Acceptability of an Abbreviated Treatment with CT-156 in People with Schizophrenia

NCT06486948 is registered in ClinicalTrials.gov with Click Therapeutics, Inc. as lead sponsor.

NCT NCT06486948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06486948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Exploratory, Randomized, Double-Arm, 8-week Study to Evaluate the Feasibility and Acceptability of an Abbreviated Treatment with CT-156 in People with Schizophrenia
Lead sponsor
Click Therapeutics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 6, 2024
Completion date
August 9, 2024
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia